Balanced news tone
News Sentiment
XBIT sentiment intelligence
XBiotech Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
78/100 classification confidence.
directly relevant articles
high-authority source matches
-0.4% over one week, -2.1% over four weeks, trend inactive, and below fair value.
XBiotech (XBIT) Holds Steady at $2.29 as Range-Bound Trading Continues - IPO Entry Watch
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
XBiotech: Q1 Earnings Snapshot
XBiotech Inc. (XBIT) reported a first-quarter loss of $5.5 million, translating to 18 cents per share. This financial snapshot was generated using data from Zacks Investment Research.
- Tone
- Negative 29/100
- Event
- Earnings
- Published
- 29 May 2026 06:41
- Source
- Barchart.com
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
Xbiotech (XBIT) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Apr 2025 23:03
- Source
- Stock Titan
First look: XBiotech to expand Austin HQ with more offices, state-of-the-art R&D facility
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Dec 2020 08:00
- Source
- The Business Journals
Xbiotech Stock Price Forecast. Should You Buy XBIT?
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 02 Dec 2020 17:57
- Source
- StockInvest.us
Janssen to Acquire Investigational Bermekimab from XBiotech
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 07 Dec 2019 08:00
- Source
- PR Newswire
Technical Analysis of XBiotech Inc. (NASDAQ:XBIT)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Feb 2018 18:07
- Source
- TradingView
XBIT Stock Price and Chart — NASDAQ:XBIT
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jul 2017 05:24
- Source
- TradingView
XBiotech (XBIT) Stock Price, News & Analysis $XBIT
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Aug 2016 04:32
- Source
- MarketBeat
XBIT: XBiotech Inc Latest Stock Price, Analysis, News and Trading Ideas
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Nov 2015 03:16
- Source
- Stocktwits